ID

24028

Description

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone; ODM derived from: https://clinicaltrials.gov/show/NCT00528879

Lien

https://clinicaltrials.gov/show/NCT00528879

Mots-clés

  1. 23/07/2017 23/07/2017 -
  2. 23/07/2017 23/07/2017 -
Téléchargé le

23 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Type 2 Diabetes NCT00528879

Eligibility Type 2 Diabetes NCT00528879

Criteria
Description

Criteria

males and females, 18 to 77 years old, with type 2 diabetes and inadequate glycemic control
Description

ID.1

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0011860
participants who have been receiving metformin at a total daily dose ≥1500 mg per day for at least 8 weeks
Description

ID.2

Type de données

boolean

Alias
UMLS CUI [1]
C0025598
c-peptide ≥1.0 ng/ml
Description

ID.3

Type de données

boolean

Alias
UMLS CUI [1]
C0202100
body mass index ≤45.0 kg/m^2
Description

ID.4

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
serum creatinine level <1.50 mg/dl for men or <1.40 mg/dl for women.
Description

ID.5

Type de données

boolean

Alias
UMLS CUI [1]
C0600061
key exclusion criteria
Description

key exclusion criteria

aspartate aminotransferase and/or alanine aminotransferase level >3.0 times the upper limit of normal
Description

ID.7

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004002
UMLS CUI [1,2]
C0001899
serum total bilirubin level >2 mg/dl
Description

ID.8

Type de données

boolean

Alias
UMLS CUI [1]
C1278039
creatinine kinase level >3 times upper limit of normal
Description

ID.9

Type de données

boolean

Alias
UMLS CUI [1]
C1657311
symptoms of severely uncontrolled diabetes
Description

ID.10

Type de données

boolean

Alias
UMLS CUI [1]
C0810250
serum creatinine level 1.50 mg/dl for men or 1.40 mg/dl for women
Description

ID.11

Type de données

boolean

Alias
UMLS CUI [1]
C0600061
currently unstable or serious cardiovascular, renal, hepatic, hematologic, oncologic, endocrine, psychiatric, or rheumatic diseases
Description

ID.12

Type de données

boolean

Alias
UMLS CUI [1,1]
C0443343
UMLS CUI [1,2]
C0012634

Similar models

Eligibility Type 2 Diabetes NCT00528879

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
ID.1
Item
males and females, 18 to 77 years old, with type 2 diabetes and inadequate glycemic control
boolean
C0001779 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
ID.2
Item
participants who have been receiving metformin at a total daily dose ≥1500 mg per day for at least 8 weeks
boolean
C0025598 (UMLS CUI [1])
ID.3
Item
c-peptide ≥1.0 ng/ml
boolean
C0202100 (UMLS CUI [1])
ID.4
Item
body mass index ≤45.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
ID.5
Item
serum creatinine level <1.50 mg/dl for men or <1.40 mg/dl for women.
boolean
C0600061 (UMLS CUI [1])
Item Group
key exclusion criteria
ID.7
Item
aspartate aminotransferase and/or alanine aminotransferase level >3.0 times the upper limit of normal
boolean
C0004002 (UMLS CUI [1,1])
C0001899 (UMLS CUI [1,2])
ID.8
Item
serum total bilirubin level >2 mg/dl
boolean
C1278039 (UMLS CUI [1])
ID.9
Item
creatinine kinase level >3 times upper limit of normal
boolean
C1657311 (UMLS CUI [1])
ID.10
Item
symptoms of severely uncontrolled diabetes
boolean
C0810250 (UMLS CUI [1])
ID.11
Item
serum creatinine level 1.50 mg/dl for men or 1.40 mg/dl for women
boolean
C0600061 (UMLS CUI [1])
ID.12
Item
currently unstable or serious cardiovascular, renal, hepatic, hematologic, oncologic, endocrine, psychiatric, or rheumatic diseases
boolean
C0443343 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial